Amanote Research
Register
Sign In
Immunohistochemical Evaluation of Β-Catenin Marker in Papillary Thyroid Cancer Clinicopathologic Behavior
doi 10.30699/ijp.13.2.151
Full Text
Open PDF
Abstract
Available in
full text
Date
April 1, 2018
Authors
Unknown
Publisher
Farname, Inc.
Related search
Β-Catenin as a Morpho-Immunohistochemical Marker for the Diagnosis of Papillary Thyroid Carcinoma
Archives of Pathology and Laboratory Medicine
Medicine
Forensic Medicine
Pathology
Medical Laboratory Technology
CircRNA circRNA_102171 Promotes Papillary Thyroid Cancer Progression Through Modulating CTNNBIP1-dependent Activation of Β-Catenin Pathway
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Columnar Cell Variant of Papillary Thyroid Carcinoma: A Clinicopathologic Analystis
European Journal of Clinical and Biomedical Sciences
Immunohistochemical Expression of ER-α and PR in Papillary Thyroid Carcinoma
ecancermedicalscience
Cancer Research
Oncology
Evaluation of Allelic Alterations in Short Tandem Repeats in Papillary Thyroid Cancer
Molecular genetics & genomic medicine
Genetics
Molecular Biology
Underexpression of INPPL1 Is Associated With Aggressive Clinicopathologic Characteristics in Papillary Thyroid Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Rs965513 Polymorphism as a Common Risk Marker Is Associated With Papillary Thyroid Cancer
Oncotarget
Oncology
In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer
Cancers
Cancer Research
Oncology
Papillary Thyroid Cancer in Three Children
Pediatric Endocrinology, Diabetes and Metabolism
Child Health
Endocrinology
Perinatology
Pediatrics
Metabolism
Diabetes